Pacific Biosciences Of California (PACB) Assets (2010 - 2026)
Pacific Biosciences Of California (PACB) posted quarterly Assets of $782.4 million for Q1 2026, down 9.11% year-over-year from $860.8 million in Q1 2025, and little changed quarter-over-quarter from $784.1 million in Q4 2025.
Pacific Biosciences Of California (PACB) Assets (2010 - 2026) Analysis & Trends
Pacific Biosciences Of California's Assets history runs 17 years deep, the most recent figure standing at $782.4 million for Q1 2026.
- In Q1 2026, Assets fell 9.11% year-over-year to $782.4 million; the TTM figure through Mar 2026 stood at $782.4 million (down 9.11% YoY), while the FY2025 annual figure was $784.1 million, down 37.79% from the prior year.
- Assets for Q1 2026 stood at $782.4 million, roughly flat from $784.1 million in the prior quarter.
- The five-year high for Assets was $1.9 billion in Q1 2022, with the low at $782.4 million in Q1 2026.
- The 5-year median for Assets is $1.7 billion (2024), against an average of $1.5 billion.
- The sharpest annual moves came in 2022 and 2025: Assets surged 56688.92% in 2022, then tumbled 48.45% in 2025.
- Pacific Biosciences Of California's Assets stood at $1.8 billion in 2022, then fell by 1.19% to $1.7 billion in 2023, then declined by 27.81% to $1.3 billion in 2024, then sank by 37.79% to $784.1 million in 2025, then slipped by 0.22% to $782.4 million in 2026.
- Business Quant data shows PACB's Assets at $782.4 million in Q1 2026, $784.1 million in Q4 2025, and $803.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.19 Bn | 194.59 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Stryker | 129.95 Bn | 126.47 Bn | 4.50 Bn | 47.93 Bn |
| 3 | Medtronic | 120.06 Bn | 110.84 Bn | 6.41 Bn | 93.03 Bn |
| 4 | Boston Scientific | 74.14 Bn | 73.60 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 52.74 Bn | 48.49 Bn | 1.35 Bn | 13.87 Bn |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn | 6.46 Bn |
| 7 | GE HealthCare Technologies | 34.20 Bn | 32.10 Bn | 2.18 Bn | 37.25 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.13 Bn | 4.55 Bn | 31.04 Bn |
| 9 | Steris | 23.25 Bn | 22.77 Bn | 684.20 Mn | 10.74 Bn |
| 10 | Pacific Biosciences Of California | 396.09 Mn | 159.21 Mn | 12.64 Mn | 751.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 751.85 Mn |
| Mar 31, 2026 | 782.37 Mn |
| Dec 31, 2025 | 784.08 Mn |
| Sep 30, 2025 | 803.16 Mn |
| Jun 30, 2025 | 825.47 Mn |
| Mar 31, 2025 | 860.79 Mn |
| Dec 31, 2024 | 1.26 Bn |
| Sep 30, 2024 | 1.45 Bn |
| Jun 30, 2024 | 1.51 Bn |
| Mar 31, 2024 | 1.67 Bn |
| Dec 31, 2023 | 1.75 Bn |
| Sep 30, 2023 | 1.90 Bn |
| Jun 30, 2023 | 1.85 Bn |
| Mar 31, 2023 | 1.90 Bn |
| Dec 31, 2022 | 1.77 Bn |
| Sep 30, 2022 | 1.82 Bn |
| Jun 30, 2022 | 1.88 Bn |
| Mar 31, 2022 | 1.94 Bn |
| Dec 31, 2021 | 2.01 Bn |
| Sep 20, 2021 | 3.20 Mn |